49 results
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
by some modification in the formation and/or distribution of the active moieties associated with the drug and (ii) targets cancers for which a single
8-K
EX-99.1
1a6ec
18 May 23
Regulation FD Disclosure
3:24pm
8-K
EX-99.1
rmtem9
4 Aug 22
Regulation FD Disclosure
9:30am
8-K
EX-99.1
bqcvvq00
13 Aug 21
Processa Pharmaceuticals Announces Second Quarter 2021 Results and Provides Corporate Update
6:16am
424B4
affbiiqj8p1a9 ej1
5 Oct 20
Prospectus supplement with pricing info
4:16pm